Month: March 2013

  • By Sherri Oslick — About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases. Eli Lilly and Company et al. v. Genentech, Inc. et al.4:13-cv-00919; filed February 28, 2013 in the Northern District of California • Plaintiffs:  Eli Lilly and Company; Imclone Systems LLC• Defendants:  Genentech, Inc.; City of…

  • March 5-6, 2013 – Medical Device Patents*** (American Conference Institute) – Chicago, IL March 7, 2013 – Implementing the New Priority Rules Under the AIA (Technology Transfer Tactics) – 1:00 – 2:00 pm (Eastern) March 7, 2013 – Patent Inventorship: Best Practices for Determination and Correction (Strafford) – 1:00 – 2:30 pm (EST) March 10-13,…

  • Strafford will be offering a webinar/teleconference entitled "Double Patenting: Defeating Rejections and Avoiding Terminal Disclaimers" on April 4, 2013 from 1:00 – 2:30 pm (EDT).  Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner and Donna M. Meuth, Senior Patent Counsel, Intellectual Property at Eisai will provide guidance to IP counsel for understanding B…

  • The Connecticut, New Jersey, New York, and Philadelphia Intellectual Property Law Associations will be holding their 29th Annual Joint Patent Practice Seminar on April 16, 2013 in New York, NY.  The seminar will consist of five panels:  USPTO Practice, Pharmaceuticals/Life Sciences, Licensing/Foreign Practice/ITC, Ethics, and Litigation with each panel addressing a series of cases and…

  • American Conference Institute (ACI) will be holding its 5th Advanced China IP Counsel Forum on April 15-16, 2013 in Shanghai, China.  ACI faculty will offer presentations on the following topics: • IP strategy discussion: Inside the year's top China IP cases and what they mean for your IP corporate strategy;• Preparing for the impact of…